Hashimoto's and the heart: pulse, blood pressure, and cholesterol

Hashimoto's does not attack the heart directly. However, the hypothyroidism it eventually causes changes three things that a doctor measures at almost every check-up: pulse, blood pressure, and cholesterol. The good news is that most of these changes improve once your thyroid hormone levels are brought into the range determined by your doctor.

Hashimoto's is the most common cause of hypothyroidism worldwide (Patrizio et al., Frontiers in Endocrinology 2024). That is why questions about the heart arise sooner or later for most women with this diagnosis. Three come up repeatedly: why has my cholesterol gone up even though I eat the same, why is my diastolic pressure higher, and is my heart palpitations caused by my thyroid?

In my case, heart problems manifested as ventricular extrasystoles and arrhythmia whenever my hypothyroidism was not stable. The PVCs were diagnosed after I wore a 24-hour Holter monitor, and I even experienced arrhythmia during surgery.

In short:

Why the thyroid affects the heart

Thyroid hormones, primarily T3, act directly on the heart muscle and blood vessels. They determine how fast the heart beats, how strongly it contracts, and how well it relaxes between beats. They also influence how wide and elastic the blood vessels are (Udovcic et al., 2017).

When there are not enough hormones, four things happen:

  1. The heart works slower and weaker. The heart rate and contraction strength drop, so the heart pumps less blood per minute. The heart muscle struggles to relax, which doctors call diastolic dysfunction.
  2. Blood vessels constrict and become stiffer. The vessel walls do not relax as well and produce less nitric oxide. Resistance to blood flow increases, and with it, your diastolic pressure.
  3. The liver clears LDL more slowly. Thyroid hormones increase the number of LDL receptors in the liver and the activity of the enzyme that breaks down cholesterol. When these hormones are low, LDL remains in the blood longer.
  4. Other markers change as well. Mild anemia and elevated CRP and homocysteine levels are more frequently found in hypothyroidism. CRP and homocysteine are associated with atherosclerosis (Udovcic et al., 2017).

In severe, long-untreated hypothyroidism, fluid can accumulate around the heart (pericardial effusion). I mention this because it is another reason not to leave hypothyroidism untreated (Udovcic et al., 2017).

Review papers from 2024 and 2025 agree that both overt and subclinical hypothyroidism are associated with more frequent high blood pressure, poorer lipid profiles, and thicker carotid artery walls. A thicker carotid wall is an early sign of atherosclerosis (Patrizio et al., 2024; Kahaly et al., Thyroid Research 2025).

Two terms you will encounter in the text:

Pulse: why it is sometimes slow and sometimes racing

Slow pulse and fatigue during exertion

In untreated hypothyroidism, the heart beats more slowly. Thyroid hormones regulate the genes that determine heart rhythm and the receptors through which the heart responds to adrenaline. When there is not enough hormone, the pulse drops (Udovcic et al., 2017).

In overt hypothyroidism, an ECG may show sinus bradycardia (a slow but regular rhythm), a prolonged QT interval, and varying degrees of AV block, i.e., slowed impulse conduction through the heart (Patrizio et al., 2024).

Many women do not experience this as a "heart problem." They feel it as rapid fatigue, difficulty breathing on stairs or during a workout, and a feeling that their body "cannot keep up" with the effort. In subclinical hypothyroidism, the most common cardiac finding is precisely impaired relaxation of the heart muscle. It is often discovered only through reduced exercise tolerance (Patrizio et al., 2024).

Is a slow pulse dangerous? By itself, it usually is not. Unlike hyperthyroidism, hypothyroidism is associated with a lower probability of cardiac arrhythmias. The large American Framingham study found no significant link between hypothyroidism and atrial fibrillation (Udovcic et al., 2017). However, a very slow pulse accompanied by dizziness, fainting, or shortness of breath requires a medical examination, regardless of the cause.

Rapid pulse and heart palpitations

A rapid pulse and heart palpitations are a different story. With Hashimoto's, one of these three reasons is usually behind them.

  1. A transient phase of excess hormone (hashitoxicosis). Inflammation damages thyroid cells, causing them to release their hormone stores into the blood. This creates a phase of hormone excess with symptoms similar to hyperthyroidism, such as fatigue, heart palpitations, and weight changes. A review published in 2025 states that this occurs in about 4–10% of patients and is easily mistaken for Graves' disease. The difference is usually shown by TRAb antibodies, which are low or negative in hashitoxicosis (Akl and Ahmed, Problemy Endokrinologii 2025). This phase is usually temporary and may be followed by hypothyroidism (MSD Manual). More on this in the article about hashitoxicosis.
  2. An excessive dose of medication. If your TSH is consistently too low while on therapy, your body is essentially in a state of mild hormone excess. This can accelerate your heart rate. The American Thyroid Association warns that a persistently low TSH increases the risk of atrial fibrillation and stroke (ATA, 2023). If palpitations begin after a dosage increase, contact your doctor and do not change the dose yourself. See also our article on low TSH.
  3. Anxiety and panic. Fear following a diagnosis is one of the most common topics on Hashimoto's forums. Heart palpitations caused by anxiety are real and unpleasant, but they require a different approach than adjusting your medication. Read more in our article on Hashimoto's and anxiety.

Heart palpitations also have many causes unrelated to the thyroid: coffee, lack of sleep, anemia, dehydration, and heart rhythm disorders. Therefore, do not automatically attribute them to Hashimoto's. Keep a log of when they occur and show your notes to your doctor, along with your latest TSH and FT4 levels.

Blood pressure: the bottom number rises

Hypothyroidism typically raises the bottom (diastolic) pressure, which narrows the gap between the top and bottom numbers.

Why does this happen? Blood vessels do not relax as effectively, which increases resistance to blood flow. Thyroid hormones also affect the renin-angiotensin-aldosterone system, which regulates salt and water in the body. The result is diastolic hypertension, which is often salt-sensitive (Udovcic et al., 2017).

What the research shows

The picture is not entirely clear-cut, and it is fair to say so. A 2025 review summarized a number of studies:

Source for all three points: Kahaly et al., 2025.

Does therapy lower blood pressure?

For many, yes, but only moderately. A 2024 meta-analysis of 34 studies found that levothyroxine for subclinical hypothyroidism lowered blood pressure by an average of about 4 mmHg (systolic) and 2 mmHg (diastolic). An earlier 2018 analysis showed that the effect in randomized trials is smaller than in observational studies. The authors therefore warn that observational studies likely overestimate the benefit (Kahaly et al., 2025).

In cases of overt hypothyroidism, therapy can reduce high blood pressure and improve blood vessel function (American Family Physician, 2004). However, it is not a guarantee. In a follow-up of 621 people on levothyroxine in Brazil, the use of blood pressure medication increased over the years. The authors of the review therefore recommend that blood pressure be checked regularly even in those who are on therapy (Kahaly et al., 2025).

What this means for you

Cholesterol: Why it rises and what lowers it

Hypothyroidism is one of the most common "hidden" causes of elevated cholesterol. It is estimated that up to 90% of people with overt hypothyroidism have lipid disorders (Kahaly et al., 2025). Total cholesterol, LDL, and apolipoprotein B levels rise, and triglycerides often increase as well. HDL, the "good" cholesterol, varies from person to person (Udovcic et al., 2017; Kahaly et al., 2025).

Why it rises

In hypothyroidism, two things happen simultaneously (Kahaly et al., 2025):

This is why many women see their cholesterol rise "out of nowhere," even though they are eating the same as before. In research, TSH levels are linked to total cholesterol, LDL, and apolipoprotein B: the higher the TSH, the higher these values (Kahaly et al., 2025).

It is also important to know that hypothyroidism can be almost asymptomatic. In one documented case, a man with a TSH over 100 mU/L had no classic signs of hypothyroidism. His elevated cholesterol was therefore misinterpreted as a primary lipid disorder unrelated to the thyroid and treated with a statin, leading to severe muscle complications (Bar et al., Canadian Family Physician 2007).

What therapy reveals

Treating the thyroid lowers cholesterol, but only moderately. A meta-analysis of 12 randomized studies involving 940 subjects with subclinical hypothyroidism found that levothyroxine lowers total cholesterol by an average of about 0.29 mmol/L and LDL by about 0.22 mmol/L. HDL and triglycerides did not change significantly. The effect was present even in mild cases with a TSH below 10. In long-term follow-ups (longer than six months), the decrease was smaller but still significant (Li et al., Clinical Endocrinology 2017).

In cases of overt hypothyroidism, the decrease is usually greater. It drops the most in those who had the highest TSH and the highest lipid levels before therapy (American Family Physician, 2004).

In practice, this means: if your LDL was perfectly normal before your diagnosis and then rose along with your TSH, it will likely improve at least partially once your hormones are balanced. If it was elevated before, the thyroid is likely not the only cause.

Before statins – check your TSH

The authors of the aforementioned case recommend that thyroid status always be checked before starting cholesterol medication. For those already taking a statin, it should be checked if muscle pain occurs or if the medication is not "working" as it should. Untreated hypothyroidism increases the risk of muscle damage while on statins. Once hormones are balanced, the statin can be cautiously reintroduced (Bar et al., 2007).

If you are already taking a statin, do not stop it on your own. Elevated cholesterol is common and can exist independently of the thyroid. A 2025 review emphasizes that it should be treated according to standard cardiology guidelines, with hormone adjustments made when necessary (Kahaly et al., 2025). If you experience muscle pain or cramps while on a statin, contact your doctor and ask about your TSH.

Diet is part of the picture, not a replacement for therapy

When hormone levels are in range, diet and exercise remain the primary levers for managing cholesterol and blood pressure, just as they are for women without Hashimoto's. I write about what that looks like with Hashimoto's in the article Hashimoto's Diet and in the text about nutrition for hypothyroidism.

Long-term heart risk: TSH is what matters most

Heart risk does not increase simply from a Hashimoto's diagnosis. It increases when TSH remains too high for a long time, and to some extent when it is consistently too low while on therapy. That is why regular TSH monitoring is the most important thing you can do for your heart.

What the largest studies say

The most well-known analysis on this topic combined data from 55,287 people across 11 studies in the US, Europe, Australia, Brazil, and Japan, tracked between 1972 and 2007 (Rodondi et al., JAMA 2010):

A more recent British study tracked 162,369 people with hypothyroidism. With a TSH above 10 mIU/L, the risk of ischemic heart disease was 18% higher, and the risk of heart failure was 42% higher than with a TSH in the middle of the normal range. Overall mortality was higher even with a TSH above 4 mIU/L (Patrizio et al., 2024, citing Thayakaran et al., BMJ 2019).

Your lab results and questions for your doctor

TSH (approximate)What studies showWhat to ask your doctor
10 mIU/L and higherThe clearest increase in the risk of coronary heart disease and heart failure (Rodondi, 2010; Patrizio, 2024). The 2013 European Thyroid Association guidelines recommend treatment for people under 65 (Udovcic, 2017).Do I need treatment or a dose adjustment?
7–10 mIU/LHigher risk of death from coronary heart disease (about 1.4 times) (Rodondi, 2010).When should I repeat the test, and what are we monitoring?
4.5–7 mIU/LNo increased risk in the same analysis. In people over 65, treatment brought no noticeable benefit for symptoms or fatigue (TRUST, NEJM 2017).Are we monitoring or treating, and why?
Low or suppressed, on treatmentHigher risk of death from heart disease; a persistently low TSH raises the risk of atrial fibrillation (ATA, 2023).Is my dose too high?

These limits are for guidance only. Reference ranges vary from lab to lab, and decisions also depend on age, symptoms, pregnancy, and other medical conditions.

Age changes the equation

The benefits of treating mild, subclinical hypothyroidism appear greater in younger people:

One reason for this is that TSH naturally rises with age, and in older adults, it does not necessarily indicate disease (Udovcic et al., 2017).

For women with Hashimoto's, the findings of an observational study are also interesting: in patients who had been taking levothyroxine for more than a year, the risk of new coronary heart disease dropped to the level of people without Hashimoto's (Kahaly et al., 2025). An observational study does not prove causation, but it aligns with other data.

Neither too high nor too low TSH

The goal is not "the lower the TSH, the better," but rather a TSH level within the range determined by your doctor. A large American study followed 705,307 people on thyroid therapy. The majority were men with an average age of 67. The risk of death from heart disease was (ATA, 2023, according to Evron et al., JAMA Network Open 2022):

An older, smaller study showed similar results. In people over 60 with a TSH of 0.1 or lower, regardless of the cause, atrial fibrillation occurred in 28% over 10 years, compared to 11% in those with normal TSH (Zimmerman, Cleveland Clinic Journal of Medicine 2003, according to Sawin et al.).

Therapy and the heart: what is safe and where caution is needed

A 2025 review concludes that levothyroxine, when the dosage is guided by TSH levels, is safe for the heart as long as overdosage is avoided (Kahaly et al., 2025). In practice, three things are important.

Start slowly if you have heart disease. In older adults and people who already have heart disease, therapy is usually started with a low dose and increased gradually. The reason is that a sudden restoration of hormones can, in rare cases, cause chest pain or heart rhythm disturbances (Udovcic et al., 2017; American Family Physician, 2004). The dosage is a decision for your doctor.

Other medications can "interfere" with your dosage. About 20% of people taking levothyroxine tablets have an inadequate dosage. For about a third of them, the cause is other medications that interfere with the absorption of levothyroxine in the intestines: stomach medications (proton pump inhibitors), iron, calcium, antacids containing aluminum, and some cholesterol and kidney medications. In one study of 114 people, those who had higher TSH levels while taking such medications were the ones who developed complications like high blood pressure and elevated lipids (Patrizio et al., 2024). That is why you should always tell your doctor about all the medications and supplements you are taking.

Levothyroxine is not a weight-loss drug. A large portion of the weight gained due to hypothyroidism consists of salt and water, so you usually lose only a small amount with therapy. Taking a higher dose for weight loss leads to an overdose, which puts a strain on the heart (Kahaly et al., 2025). I write about weight gain with Hashimoto's in the article Why weight loss stalls with Hashimoto's.

What you can do for your heart with Hashimoto's

Most of the work is done by a well-adjusted therapy. The rest comes down to habits, regular check-ups, and good communication with your doctor.

  1. Get checked as your doctor advises. Check TSH and FT4 after every dosage change, and then regularly once your condition stabilizes. Do not change the dosage on your own, neither higher nor lower.
  2. Ask for a lipid panel along with your hormone tests. Total cholesterol, LDL, HDL, and triglycerides. If your cholesterol has recently increased, ask if your thyroid could be the reason behind it.
  3. Measure your blood pressure and pulse at home. At the same time of day, for several days in a row, after sitting for a few minutes. Bring the readings to your appointment.
  4. Keep a record of heart palpitations. Note when they occurred, how long they lasted, and whether they happened after taking medication, drinking coffee, exercising, or experiencing stress.
  5. Always take your medication the same way. On an empty stomach and spaced apart from coffee, food, and other medications, as directed by your doctor and the medication instructions. Inconsistent dosing causes TSH levels to fluctuate (see the article on Eutirox and the article on coffee).
  6. Tell your doctor about all medications and supplements you take. Especially iron, calcium, and stomach medications, as they can reduce the absorption of levothyroxine.
  7. Stay physically active. Movement is good for the heart and blood pressure for everyone, including those with Hashimoto's. If you are experiencing severe fatigue or a slow pulse, start slowly and focus on balancing your hormones first. I write about training with Hashimoto's in my lessons on bodybuilding preparation.
Nutrition that makes the whole process easier. In the Hashimoto's Cookbook, I have collected gluten-free and lactose-free recipes, meal plans, and guides for days when you aren't feeling well. This does not cure the thyroid or replace medical treatment, but it takes the stress out of deciding what to eat every day. Check out the cookbook.

How to prepare for your appointment

Appointments with an endocrinologist or general practitioner are often short. If you arrive prepared, you can get much more done in those few minutes.

What to bring:

Questions worth asking:

  1. What is my target TSH range, considering my age and other medical conditions?
  2. Could my cholesterol levels be a result of my thyroid condition? When should I retest after adjusting my medication?
  3. Does my blood pressure require specific treatment, or should we wait to see the effect of the thyroid medication first?
  4. Can any of my medications or supplements interfere with the absorption of levothyroxine?
  5. When should I have an EKG or an echocardiogram, and is it necessary for me at all?
  6. What symptoms should I watch out for after a dosage change?

If you are feeling anxious after your diagnosis or everything feels new, start with the basics. In my free guide for the first three weeks after diagnosis I have gathered what is good to know at the beginning and how to organize yourself for follow-up appointments.

When to see a doctor immediately

Call emergency services (911) or go to the nearest emergency room if you experience:

The 194 emergency number operates directly in Belgrade, Novi Sad, Kragujevac, and Niš. In other locations, you are often directed to the emergency service of your local health center, so save that number in your phone in advance (021.rs).

Schedule an appointment with your doctor in the coming days if:

About the author

Jana Radojčić lives with Hashimoto's and writes from personal experience, with scientific sources cited in every article. She is not a doctor. Read more about me on the page About me.

Medical Disclaimer

This text is for informational purposes and does not replace medical advice. Do not change your therapy or medication dosage without consulting your doctor. Read medical disclaimer.

Last source check: November 14, 2026.

Sources

  1. Udovcic M, Herrera Pena R, Patham B, Tabatabai L, Kansara A. Hypothyroidism and the Heart. Methodist DeBakey Cardiovascular Journal, 2017.
  2. Patrizio A, Ferrari SM, Elia G et al. Hypothyroidism and metabolic cardiovascular disease. Frontiers in Endocrinology, 2024. Publication costs were funded by the pharmaceutical company IBSA.
  3. Kahaly GJ, Liu Y, Persani L. Hypothyroidism: playing the cardiometabolic risk concerto. Thyroid Research, 2025. Editorial assistance and publication costs were funded by Merck Healthcare KGaA, the manufacturer of Euthyrox.
  4. Rodondi N et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA, 2010.
  5. Stott DJ et al. (TRUST). Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. New England Journal of Medicine, 2017.
  6. Li X, Wang Y, Guan Q, Zhao J, Gao L. The lipid-lowering effect of levothyroxine in patients with subclinical hypothyroidism. Clinical Endocrinology, 2017.
  7. American Thyroid Association. Overtreatment and under treatment of hypothyroidism with thyroid hormone is associated with increased death from heart disease. Clinical Thyroidology for the Public, February 2023 (summary of study by Evron JM et al., JAMA Network Open 2022).
  8. Bar SL, Holmes DT, Frohlich J. Asymptomatic hypothyroidism and statin-induced myopathy. Canadian Family Physician, 2007.
  9. Zimmerman RS. What is the target TSH level in thyroid hormone replacement for primary hypothyroidism? Cleveland Clinic Journal of Medicine, 2003.
  10. Treating Hypothyroidism Reduces Atherosclerosis Risk (summary of the paper by Cappola and Ladenson). American Family Physician, 2004.
  11. Akl M, Ahmed A. Clinical Case Series of Destructive Thyrotoxicosis Associated with Hashimoto’s Thyroiditis Misdiagnosed as Graves’ Disease. Problemy Endokrinologii, 2025.

Additional resources: MSD Manual Professional Edition – Hyperthyroidism (thyroiditis: release of stored hormones and subsequent hypothyroidism); 021.rs – emergency services in Serbia.

FREQUENTLY ASKED QUESTIONS